Last reviewed · How we verify

NCT04873947

Belun SpO2 Accuracy Comparison to Arterial Blood CO-Oximetry

Completed Last updated 5 May 2021
What this trial tests

trial testing Pulse Oximeter in Hypoxia in 10 participants. Completed in 28 August 2020.

Timeline
25 August 2020
Primary endpoint
28 August 2020
28 August 2020

Quick facts

Lead sponsorBelun Technology Company Limited
StatusCompleted
Study typeOBSERVATIONAL
Enrollment10
Start date25 August 2020
Primary completion28 August 2020
Estimated completion28 August 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Belun Technology Company Limited

Who can join

Adults 18 to 50, any sex, with Hypoxia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was a comparative, single-center, non-randomized study conducted to evaluate the SpO2 accuracy per standards and guidelines identified above for SpO2 accuracy for pulse oximetry equipment over the range of 70-100% SaO2 under non-motion conditions. Arterial blood sampling measured by functional SaO2 CO-Oximetry, was used as the basis for comparison. Testing was conducted under normal office environment conditions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Pulse Oximeter

Trials testing the same drug.

Other recruiting trials for Hypoxia

Currently open trials in the same condition.

Other Belun Technology Company Limited trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04873947.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing